GLOBAL PHARMATECH, INC.

GLOBAL PHARMATECH, INC.

Previous company name
AUTOCARBON, INC.
Name change date
1/31/2005
Company Overview
Global Pharmatech, Inc. (Global) is a public quoted company engaged in the provision of management services for subsidiaries engaged in the production and distribution of drugs and nutritional supplements. The company was incorporated in June of 2001. It was previously known as Autocarbon, Inc. Global Pharmatech has registered business office based in Delaware, United States.
The company principally holds the activities involved in the development of over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; dietary supplement; prescription drug used for the treatment of common colds, especially for children; anti-upper respiratory infection drug; feminine care drug; drug for various stomachaches; and treatment of angina and other coronary diseases. It also handles the activities involved in the manufacturing and selling of other proprietary drugs, generics, and dietary supplements used to treat various symptoms, such as headaches, coughing, dry mouth, infections, and numbness of limbs.
Global Pharmatech also licenses patents and technologies for botanical/biological drug and nutritional supplements. The company also manages business operations that are conducted in the People’s Republic of China with sales distribution sites in China, the United States, Hong Kong, Malaysia, Singapore, Indonesia and Vietnam.
Business Summary
Global Pharmatech, Inc. (Global) is engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, Traditional Chinese Medicine (TCM) and dietary supplements using internationally accepted scientific standards. Global’s product line consists of 20 drugs and two dietary supplements. These are primarily TCM-based prescription drugs, over-the-counter drugs and dietary supplements, including two western medicines. The Company sells its products through distributors and directly to consumers through its own sales team. The Company markets its expertise in three major ways: sales of medicine and dietary supplements in convenient dosage forms, such as capsules and pills, revenues from technology transfer, and revenues derived from conducting experiments and research for other companies. TCM accounts for approximately 30% of all medicines sold in China.
Description and history
Global Pharmatech, Inc. (Global), incorporated on June 26, 2001, is engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, Traditional Chinese Medicine (TCM) and dietary supplements using internationally accepted scientific standards. Global’s product line consists of 20 drugs and two dietary supplements. These are primarily TCM-based prescription drugs, over-the-counter drugs and dietary supplements, including two western medicines. The Company sells its products through distributors and directly to consumers through its own sales team.

On March 15, 2007, JTY acquired a 75% equity interest in Jilin Biotech, Inc. (JBI), which is engaged in the manufacturing and sales of dietary supplements. On May 11, 2007, JTY acquired a 95% equity interest in Jilin Yicaotang Pharmaceutical Co., Ltd (YCT), which is in the business of liquid dose medicine manufacturing and sales. On September 7, 2007, Changchun Xiandai Technology Inc., a subsidiary of the Company, changed its name to Jilin Tianyao Xiandai TCM Technology Limited (JLXD).

The Company markets its expertise in three major ways: sales of medicine and dietary supplements in convenient dosage forms such as capsules and pills, revenues from technology transfer, and revenues derived from conducting experiments and research for other companies. TCM accounts for approximately 30% of all medicines sold in China.

The XS Capsule (Xin-Shu) is a State Food and Drug Administration (SFDA)-approved prescription drug indicated for the treatment of angina and other coronary disease. It has been developed by using modern biotechnologies. The drug substances of XS were extracted from six Chinese medical herbal materials. The safety and efficacy of these drug substances and their combination were tested in previous clinical trials conducted in China.

The Jutai Soft Capsule is an SFDA-approved dietary supplement with three patents including 1 innovation patent. Substances of this product are extracted from American ginseng and Echinacea Purpurea, a plant originally grown in North America. This dietary supplement and energy provider was developed by the Company. As shown in the Company’s own study, Echinacea Purpurea may increase the concentration of blood leukocyte and enhance general human immunity. In addition, Jutai is approved for sale to combat fatigue and to enhance general human immunity.

Qingxuan Anti-Hypertension Tablet is an SFDA-approved over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level. The drug substance of Qingxuan is extracted from a single Chinese medical herb, radish seed. The extract contains methyl mercaptan, erucic acid, octadecatrienoic acid, nC13, Glycerol sinapate, raphanin, cyanidin and coumarin. Pharmacology experiments showed that Qingxuan may reduce blood pressure in several animal models. In a three-month toxicity study, after Qingxuan was orally given to mice at 10 to 40 times greater than a human clinical dose (based on body surface areas), no mortality or organ toxicity was observed in the animal tested. As an over-the-counter drug product, these tablets can be marketed in China without prescription. Yanreqing Tablet is an SFDA-approved prescription drug to treat inflammation. In addition to these patented products, Global manufactures and sells other drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs.

Previously known as Autocarbon, Inc

Business Line
Provision of management services for subsidiaries engaged in the production and distribution of drugs and nutritional supplements
Subsidiary

Advisor
MOORE STEPHENS LLP
IPO date
4/25/2002
US SIC Code
2833
Company Address

City province or state postal code
DE
Phone:
Fax:
Country address: UNITED STATES OF AMERICA
Website url: www.global-pharmatech.com